Rationale and Design of the Multicenter Trial on Japan Working Group on the Effects of Angiotensin Receptor Blockers Selection (Azilsartan vs. Candesartan) on Diastolic Function in the Patients Suffering from Heart Failure with Preserved Ejection Fraction: J-TASTE Trial
Masafumi Kitakaze(Hanwa Memorial Hospital), Taishi Sasaoka(Osaka Prefectural Medical Center), Ken‐ichi Matsuoka(Okayama University), Shinya Hiramitsu(Nagoya Heart Center), Yoji Nagata(Fukui CardioVascular Center), Nobuyuki Ohte(Nagoya City University), Toshihisa Anzai(Hokkaido University), Kazuo Kimura(Yokohama City University Medical Center), Yukio Ozaki(Kyushu University), Masanori Asakura(National Cerebral and Cardiovascular Center), Shunsuke Tamaki(Osaka Prefectural Medical Center), Toshimitsu Hamasaki(National Cerebral and Cardiovascular Center), Hiroya Kawai(Kobe University), Hidetaka Kioka(Kindai University), Hirohiko Motoki(Shinshu University), Sunao Nakamura(New Tokyo Hospital), Kazutaka Aonuma(Mito Saiseikai General Hospital), Yukio Abe(Osaka City General Hospital), Takaharu Hayashi(Osaka Police Hospital), Young-Jae Lim(Kamiichi General Hospital), Hiroyuki Takahama(Tohoku University), Masayoshi Ajioka(University of Tsukuba)
Cited by 4
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
|New England Journal of Medicine|2011|1.1k
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Right Ventricular Function in Heart Failure With Preserved Ejection Fraction
|Circulation|2014|456